British Journal of Cancer - Table of Contents alert Volume 114 Issue 6

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 114, Issue 6 (605-712) Published online 15 March 2016 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Minireview Top Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia Elena Ceccacci and Saverio Minucci Br J Cancer 2016 114: 605-611; advance online publication, February 23, 2016; 10.1038/bjc.2016.36 Abstract | Full Text Clinical Studies Top Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study Tal Grenader, Stephen Nash, Richard Adams, Richard Kaplan, David Fisher, Tim Maughan and John Bridgewater Br J Cancer 2016 114: 612-615; advance online publication, February 18, 2016; 10.1038/bjc.2016.23 Abstract | Full Text Clinical impact of mutation fraction in epidermal growth factor receptor mutation positive NSCLC patients Petra Martin, Carolyn J Shiau, Maria Pasic, Ming Tsao, Suzanne Kamel-Reid, Stephanie Lin, Roxana Tudor, Susanna Cheng, Brian Higgins, Ronald Burkes, Matilda Ng, Saroosh Arif, Peter M Ellis, Stacy Hubay, Sara Kuruvilla, Scott A Laurie, Jing Li, David Hwang, Anthea Lau, Frances A Shepherd, Lisa W Le and Natasha B Leighl Br J Cancer 2016 114: 616-622; advance online publication, February 18, 2016; 10.1038/bjc.2016.22 Abstract | Full Text Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis Robert S Phillips, Lillian Sung, Roland A Amman, Richard D Riley, Elio Castagnola, Gabrielle M Haeusler, Robert Klaassen, Wim J E Tissing, Thomas Lehrnbecher, Julia Chisholm, Hana Hakim, Neil Ranasinghe, Marianne Paesmans, Ian M Hann and Lesley A Stewart on behalf of the PICNICC Collaboration Br J Cancer 2016 114: 623-630; advance online publication, March 8, 2016; 10.1038/bjc.2016.28 Abstract | Full Text Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis Xuan-Anh Phi, Sepideh Saadatmand, Geertruida H De Bock, Ellen Warner, Francesco Sardanelli, Martin O Leach, Christopher C Riedl, Isabelle Trop, Maartje J Hooning, Rodica Mandel, Filippo Santoro, Gek Kwan-Lim, Thomas H Helbich, Madeleine MA Tilanus-Linthorst, Edwin R van den Heuvel and Nehmat Houssami Br J Cancer 2016 114: 631-637; advance online publication, February 23, 2016; 10.1038/bjc.2016.32 Abstract | Full Text Translational Therapeutics Top BH3 profiling and a toolkit of BH3-mimetic drugs predict anti-apoptotic dependence of cancer cells Michael Butterworth, Andrew Pettitt, Shankar Varadarajan and Gerald M Cohen Br J Cancer 2016 114: 638-641; advance online publication, March 8, 2016; 10.1038/bjc.2016.49 Abstract | Full Text Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma Martin H Voss, David Chen, Mahtab Marker, A Ari Hakimi, Chung-Han Lee, James J Hsieh, Jennifer J Knox, Maurizio Voi and Robert J Motzer Br J Cancer 2016 114: 642-649; advance online publication, February 23, 2016; 10.1038/bjc.2016.21 Abstract | Full Text Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors Timon Vandamme, Matthias Beyens, Ken Op de Beeck, Fadime Dogan, Peter M van Koetsveld, Patrick Pauwels, Geert Mortier, Christel Vangestel, Wouter de Herder, Guy Van Camp, Marc Peeters and Leo J Hofland Br J Cancer 2016 114: 650-658; 10.1038/bjc.2016.25 Abstract | Full Text Androgen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition N M Byrne, H Nesbitt, L Ming, S R McKeown, J Worthington and D J McKenna Br J Cancer 2016 114: 659-668; advance online publication, March 8, 2016; 10.1038/bjc.2016.29 Abstract | Full Text Optimising the combination dosing strategy of abemaciclib and vemurafenib in BRAF-mutated melanoma xenograft tumours Sonya C Tate, Teresa F Burke, Daisy Hartman, Palaniappan Kulanthaivel, Richard P Beckmann and Damien M Cronier Br J Cancer 2016 114: 669-679; 10.1038/bjc.2016.40 Abstract | Full Text Molecular Diagnostics Top Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia Claudia A Penafuerte, Bruno Gagnon, Jacinthe Sirois, Jessica Murphy, Neil MacDonald and Michel L Tremblay Br J Cancer 2016 114: 680-687; advance online publication, March 8, 2016; 10.1038/bjc.2016.3 Abstract | Full Text Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survival A M Kamal, J N Bulmer, S B DeCruze, H F Stringfellow, P Martin-Hirsch and D K Hapangama Br J Cancer 2016 114: 688-696; advance online publication, March 1, 2016; 10.1038/bjc.2016.16 Abstract | Full Text Ectopic expression of the chemokine CXCL17 in colon cancer cells Lina Ohlsson, Marie-Louise Hammarström, Gudrun Lindmark, Sten Hammarström and Basel Sitohy Br J Cancer 2016 114: 697-703; advance online publication, February 18, 2016; 10.1038/bjc.2016.4 Abstract | Full Text Mimicking the tumour microenvironment of chronic lymphocytic leukaemia in vitro critically depends on the type of B-cell receptor stimulation Ans Rombout, Sofie Lust, Fritz Offner, Evelien Naessens, Bruno Verhasselt and Jan Philippé Br J Cancer 2016 114: 704-712; advance online publication, February 25, 2016; 10.1038/bjc.2016.35 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.